As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Subgroup analysis in clinical trials constitutes a vital methodological tool to uncover differential treatment effects within specified categories of patients. This approach enables researchers to ...

A research team has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease. Scientists used their tool, named Merlin, to assess 3D ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support ...

We analyzed 4,427 patients with MDS divided into training and validation cohorts. Deep learning methods were applied to integrate and impute clinical/genomic features. Clustering was performed by ...

Recent developments at Viking Therapeutics have presented market participants with two distinct signals to interpret. While a major institutional investor made ...

Critical bleeding remains one of the most time-sensitive and high-stakes conditions in modern medicine. Whether occurring in trauma, major surgery, ...

This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge. Results: There were 31 studies that met ...

Palliative Radiotherapy Near the End of Life: An Analysis of Factors Influencing the Administration of Radiotherapy in Advanced Tumor Disease Clinical trial activity in radiation oncology has ...

As Altimmune moves beyond its 2025 fiscal year, the biopharmaceutical firm is squarely focused on a series of pivotal ...

Q4 2025 earnings call: ivonescimab Phase III updates, FDA PDUFA timeline, interim PFS in Q2 2026, cash position—read now.